ONC - BeiGene Oncology Revenue Growth Rate YoY (Last Twelve Months)

Brandmark of beigene.com (ONC)

BeiGene Ltd (ONC) operates in a defensive sector where demand for therapy remains stable across any economic cycle. The rolling 12-month sales growth rate year-over-year demonstrates revenue dynamics, while 33.00 expresses the current value of this metric. The company aims to become a global disruptor, leveraging its Chinese base to capture Western markets. A breakthrough R&D pipeline of new inhibitors ensures the competitiveness of its innovations.

BeiGene Oncology (ONC) Sales Growth YoY (Last Twelve Months): for the period 02/11/2024 - 11/18/2026

BeiGene - analytical breakdowns and key metrics (ONC)

- stock value and consensus price forecast:
Analysis of all company metrics:BeiGene Ltd (ONC)
Manufactured product of beigene.com

BeiGene Ltd strategic alliances in oncology and molecule licensing translate directly into revenue scaling, as reflected in the LTM annual sales growth. This indicator calculates the percentage shift in revenue over the trailing twelve months relative to the previous year, allowing investors to assess the real pace of business expansion and its resilience to market shocks without quarterly distortions.

Competitor analysis for BeiGene Ltd

Sales Growth YoY (TTM) Halozyme Corp HALO|RVMD: Revenue Growth YoY (Last 12 Months)|Ascentage Pharma Group (AAPG) - Revenue Growth YoY (Last 12 Months)|CG Oncology Therapeutics (CGON) - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) UroGen Pharma URGN|Sales Growth YoY (Last Twelve Months) Bicara Bio|Trailing Twelve Months Revenue Growth Personalis Genomics PSNL|Sales Growth YoY (TTM) ERAS|Revenue Change YoY (Last 12 Months) DCTH|Y-mAbs Therapeutics, Inc. - Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) Aura Biosciences Inc (AURA)|CADL: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) ARAY (Accuray Inc.)|SLS: Sales Growth YoY (TTM)|ACTU: Revenue Change YoY (Last 12 Months)|CTOR (Citius Oncology Inc.) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth tuhurabio.com HURA|Sales Growth YoY (TTM) TARA|FATE: Trailing Twelve Months Sales Growth|Sales Growth YoY (TTM) WHWK (Aadi Bioscience)|TCRX (TScan) - Trailing Twelve Months Sales Growth|Champions Oncology, Inc. - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) XBiotech Inc XBIT|CVM: Sales Growth YoY (TTM)|OSTX - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Radiopharm Theranostics Limited|Sales Growth YoY (TTM) artivabio.com|Revenue Growth YoY (Last 12 Months) ANL (Adlai Nortye Limited)|Veru - Sales Growth YoY (Last 12 Months)|Tempest Therapeutics, Inc. - Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) xiliotx.com (XLO)|Renovaro - Sales Growth YoY (TTM)|Mural Oncology (MURA) - Revenue Growth YoY (Last 12 Months)|KAPA: Sales Growth YoY (TTM)|OKUR - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) CytoMed Therapeutics Limited|CRIS: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) APLM|Sales Growth YoY (TTM) tharimmune.com (THAR)|Advanced Biomed Corp - Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) GNPX|Calidi Biotherapeutics, Inc. - Sales Growth YoY (TTM)|Sunshine Biopharma (SBFM) - Revenue Growth YoY (Last 12 Months)|XBIO: Sales Growth YoY (TTM)|SLRX - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) PPBT|Sales Growth YoY (TTM) American Oncology Network|Sales Growth YoY (Last Twelve Months) BeOne Medicines (BGNE)|CKPT: Trailing Twelve Months Sales Growth|Sales Growth YoY (TTM) ELEV (Elevation Oncology Inc.)|Sales Growth YoY (TTM) iCAD Corp ICAD|Ikena - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) NTBL (Notable Labs)|VIRX: Sales Growth YoY (TTM)|Trailing Twelve Months Sales Growth MOR (MorphoSys Corp)|Sales Growth YoY (Last Twelve Months) NAYA Biosciences|Sales Growth YoY (TTM) ascentage.com